Skip to main content
. 2018 Mar 29;9:2151459318764151. doi: 10.1177/2151459318764151

Table 4.

Complications and Discharge Disposition for Nonanticoagulated Cohort and Anticoagulated Cohort.

Nonanticoagulated (n = 367) Anticoagulated (n = 112) P Valuea Odds Ratio (OR); 95% CI; P Value)b
Sepsis, n (%) 7 (1.9%) 8 (7.1%) .010 2.998; 1.036-8.673; P = .028)
Pneumonia, n (%) 25 (7.0%) 10 (8.7%) .451 1.052; 0.478-2.315; P = .900)
DVT/PE, n (%) 12 (3.3%) 3 (1.8%) .537 0.556; 0.118-2.619; P = .458)
Acute MI, n (%) 8 (2.2%) 4 (3.6%) .488 1.153; 0.333-3.987; P = .822)
Acute kidney injury, n (%) 33 (9.0%) 18 (16.1%) .033 1.572; 0.822-3.007; P = .172)
Stroke, n (%) 2 (0.5%) 0 (0.0%) .000 0.000; 0.000-0.000; P = .996)
Postoperative hematoma, n (%) 24 (6.5%)c 11 (9.8%)d .243 1.468; 0.675-3.194; P = .333)
Decubitus ulcer, n (%) 15 (4.1%) 4 (3.6%) .000 0.723; 0.229-2.285; P = .581)
Urinary tract infection, n (%) 54 (14.7%) 16 (14.3%) .911 0.923; 0.492-1.734; P = .804)
Acute respiratory failure, n (%) 30 (8.2%) 18 (15.2%) .029 2.021; 1.035-3.947; P = .039)
Acute anemia, n (%) 176 (48.0%) 51 (45.5%) .653 0.841; 0.541-1.308; P = .442)
Cardiac arrest, n (%) 3 (0.8%) 1 (0.9%) .000 0.721; 0.073-7.112; P = .780)
Death, n (%) 3 (0.8%) 4 (3.6%) .055 3.350; 0.688-16.308; P = .134)
Transfer to ICU/SDU, n (%) 73 (19.1%) 39 (34.8%) .001 2.364; 1.433-3.900; P = .001)
Discharged home, n (%) 73 (19.9%) 12 (10.7%) .026 0.850; 0.418-1.729; P = .654)

Abbreviations: CI, confidence interval; DVT/PE, deep vein thrombosis/pulmonary embolism; MI, myocardial infarction; ICU, intensive care unit; SDU, step-down unit.

a P values represent those associated with the χ2 analyses and Fisher exact tests comparing the nonanticoagulated and anticoagulated cohorts.

b P values represent those associated with the logistic regression model comparing the nonanticoagulated and anticoagulated cohorts (controlled for age, CCI, and anesthesia type).

cTwo patients required evacuation of hematoma.

dZero patients required evacuation of hematoma.